Operating Lease, Right-of-Use Asset of Twist Bioscience Corp from 31 Dec 2019 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Twist Bioscience Corp quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 31 Dec 2019 to 30 Sep 2025.
  • Twist Bioscience Corp Operating Lease, Right-of-Use Asset for the quarter ending 30 Sep 2025 was $49,377,000, a 16% decline year-over-year.
Source SEC data
View on sec.gov
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

Twist Bioscience Corp Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $49,377,000 -$9,452,000 -16% 30 Sep 2025 10-K 17 Nov 2025 2025 FY
Q2 2025 $51,845,000 -$9,432,000 -15% 30 Jun 2025 10-Q 04 Aug 2025 2025 Q3
Q1 2025 $54,065,000 -$9,601,000 -15% 31 Mar 2025 10-Q 05 May 2025 2025 Q2
Q4 2024 $56,475,000 -$12,618,000 -18% 31 Dec 2024 10-Q 03 Feb 2025 2025 Q1
Q3 2024 $58,829,000 -$12,702,000 -18% 30 Sep 2024 10-K 17 Nov 2025 2025 FY
Q2 2024 $61,277,000 -$10,751,000 -15% 30 Jun 2024 10-Q 02 Aug 2024 2024 Q3
Q1 2024 $63,666,000 -$7,003,000 -9.9% 31 Mar 2024 10-Q 02 May 2024 2024 Q2
Q4 2023 $69,093,000 -$4,664,000 -6.3% 31 Dec 2023 10-Q 02 Feb 2024 2024 Q1
Q3 2023 $71,531,000 -$3,417,000 -4.6% 30 Sep 2023 10-K 18 Nov 2024 2024 FY
Q2 2023 $72,028,000 -$4,137,000 -5.4% 30 Jun 2023 10-Q 07 Aug 2023 2023 Q3
Q1 2023 $70,669,000 -$7,546,000 -9.6% 31 Mar 2023 10-Q 08 May 2023 2023 Q2
Q4 2022 $73,757,000 +$1,737,000 +2.4% 31 Dec 2022 10-Q 07 Feb 2023 2023 Q1
Q3 2022 $74,948,000 +$13,368,000 +22% 30 Sep 2022 10-K 21 Nov 2023 2023 FY
Q2 2022 $76,165,000 +$13,362,000 +21% 30 Jun 2022 10-Q 08 Aug 2022 2022 Q3
Q1 2022 $78,215,000 +$47,218,000 +152% 31 Mar 2022 10-Q 06 May 2022 2022 Q2
Q4 2021 $72,020,000 +$39,690,000 +123% 31 Dec 2021 10-Q 09 Feb 2022 2022 Q1
Q3 2021 $61,580,000 +$27,881,000 +83% 30 Sep 2021 10-K/A 05 Jun 2023 2022 FY
Q2 2021 $62,803,000 +$27,739,000 +79% 30 Jun 2021 10-Q 09 Aug 2021 2021 Q3
Q1 2021 $30,997,000 -$4,856,000 -14% 31 Mar 2021 10-Q 07 May 2021 2021 Q2
Q4 2020 $32,330,000 -$4,908,000 -13% 31 Dec 2020 10-Q 09 Feb 2021 2021 Q1
Q3 2020 $33,699,000 30 Sep 2020 10-K 23 Nov 2021 2021 FY
Q2 2020 $35,064,000 30 Jun 2020 10-Q 12 Aug 2020 2020 Q3
Q1 2020 $35,853,000 31 Mar 2020 10-Q 13 May 2020 2020 Q2
Q4 2019 $37,238,000 31 Dec 2019 10-Q 10 Feb 2020 2020 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.